Beta
57400

Evaluation of Dose Related Structural Changes in Sodium-Valproate-Induced Hepatotoxicity and a Possible Protective Role of Vitamin E in Adult Albino Rats

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Background: Sodium valproate (SV) is a widely administered antiepileptic drug, although hepatotoxicity is a side effect. Vitamin E (vit. E) being a potent antioxidant agent and essential fat-soluble nutrient that can dramatically decreased this hepatotoxic effect.
Aim of the Work: To investigate the histopathological and ultrastructural changes caused by different doses of SV, observe their correlations with liver biomarker levels and assess the defensive role of vit. E against SV-hepatotoxicity.
Methods: Sixty male adult albino rats were randomly divided into six groups. Group 1 was treated with normal saline. Group 2 was treated orally with vit. E (100 mg/kg/day). Groups 3, 4 and 5 were treated intraperitoneally with SV at doses of 100, 300 and 500 mg/kg/day, respectively, for 8 consecutive days. Group 6 was treated intraperitoneally with SV (500 mg/kg/day) and orally with vit. E (100 mg/kg/day) for 8 consecutive days. On the ninth day, blood samples were collected to assess the biochemical markers of the liver, and the results were statistically analysed. The rats were deeply anaesthetized and sacrificed. Liver specimens were carefully dissected, and portions were fixed in 10% formalin solution for histopathological examination; others were fixed in 2.5% glutaraldehyde for ultrastructural study.
Results: The liver function among the different groups was found to be significantly changed in dose dependent manner. Histopathological examination showed gradual distortion of hepatic lobular architecture and infiltration of lymphocytic cells. Concerning hepatocyte ultrastructure, SV was a destructive compound for most intracellular organelles. This toxicity was most obvious in the groups treated with higher doses; however, concurrent administration of vit. E with SV provided some hepatoprotection.
Conclusion: SV is a destructive compound to the liver architecture, especially in high doses. However, SV damage can be attenuated by concurrent administration of vit. E, which considerably decreases most SV-induced hepatotoxicity.

DOI

10.21608/ejh.2019.16176.1161

Keywords

hepatoxicity, Rats, Valproic acid, Vitamin E

Authors

First Name

Reham

Last Name

Abdel-Kareem

MiddleName

H.

Affiliation

Anatomy Department, Faculty of Medicine, Zagazig University

Email

reham.helmy5@gmail.com

City

Zagazig

Orcid

0000-0001-8285-4496

First Name

Shereen

Last Name

Tawfeek

MiddleName

E.

Affiliation

Anatomy Department, Fauculty of Medicine, Zagazig University Anatomy Department, Collage of Medicine, Jouf University, Saudi Arabia

Email

shereentawfeek@gmail.com

City

Zagazig

Orcid

0000-0001-8670-2596

Volume

43

Article Issue

2

Related Issue

17203

Issue Date

2020-06-01

Receive Date

2019-09-29

Publish Date

2020-06-01

Page Start

585

Page End

597

Print ISSN

1110-0559

Online ISSN

2090-2417

Link

https://ejh.journals.ekb.eg/article_57400.html

Detail API

https://ejh.journals.ekb.eg/service?article_code=57400

Order

17

Type

Original Article

Type Code

119

Publication Type

Journal

Publication Title

Egyptian Journal of Histology

Publication Link

https://ejh.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023